Akebia Announces First Quarter 2014 Financial Results And Recent Corporate Highlights
5/12/2014 7:08:11 AM
Akebia Therapeutics, Inc. (NASDAQ:AKBA), a biopharmaceutical company focused on the development of novel, proprietary therapeutics based on hypoxia-inducible factor (HIF) biology and the commercialization of these products for patients with kidney disease, today announced financial results for the first quarter ended March 31, 2014.
Help employers find you! Check out all the jobs and post your resume.
comments powered by